AU2003236843A1 - Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders - Google Patents

Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders

Info

Publication number
AU2003236843A1
AU2003236843A1 AU2003236843A AU2003236843A AU2003236843A1 AU 2003236843 A1 AU2003236843 A1 AU 2003236843A1 AU 2003236843 A AU2003236843 A AU 2003236843A AU 2003236843 A AU2003236843 A AU 2003236843A AU 2003236843 A1 AU2003236843 A1 AU 2003236843A1
Authority
AU
Australia
Prior art keywords
cox
angiogenesis
inhibitors
pharmaceutical use
ocular disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003236843A
Inventor
Romulus Kimbro Brazzell
George N. Lambrou
Elisabeth Latour
Anna Ottlecz
Jeanette Marjorie Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2003236843A1 publication Critical patent/AU2003236843A1/en
Abandoned legal-status Critical Current

Links

AU2003236843A 2002-01-23 2003-01-22 Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders Abandoned AU2003236843A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0201520.4 2002-01-23

Publications (1)

Publication Number Publication Date
AU2003236843A1 true AU2003236843A1 (en) 2003-09-02

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003303128A1 (en) Inhibitors and methods of use thereof
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003252478A1 (en) Ccr4 antagonist and medicinal use thereof
PL375877A1 (en) Hydantoine derivatives and their use as tace inhibitors
AU2003258534A1 (en) Use of s1p receptor agonists in heart diseases
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2002306624A1 (en) Heterocyclic analgesic compounds and methods of use thereof
PL374581A1 (en) Diaminothiazoles and use thereof as cdk4 inhibitors
AU2003210983A1 (en) Kinase inhibitors and methods of use thereof
AU2003290939A1 (en) Replication of biological tiussue
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2003250317A1 (en) Device for administration of fluids
PT1503746E (en) Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003294941A1 (en) Combinations of a vanilloid antagonist and an nsaid for the treatment of pain
AU2003236843A1 (en) Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
SI1503746T1 (en) Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
AU2002339673A1 (en) Agonists and antagonists of ryzn for the treatment of metabolic disorders
AU2003240446A1 (en) Use of mob-5 in pain
AU2003264474A1 (en) Novel uracil derivatives and medicinal use thereof
AU2002328173A1 (en) Omoxin agonists and antagonists for use in the treatment of metabolic disorders
AU2003294697A1 (en) Combinations of benzodithiazoles and cox-2 inhibitors for the treatment of pain
AU2002258791A1 (en) Heterocyclic analgesic compounds and methods of use thereof
AU2002339680A1 (en) Agonists and antagonists of bromix for the treatment of metabolic disorders